- Home
- WBX vs VERU Comparison
WBX vs VERU Comparison
Compare WBX & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- VERU
- Stock Information
- Founded
- WBX 2015
- VERU 1971
- Country
- WBX Spain
- VERU United States
- Employees
- WBX N/A
- VERU N/A
- Industry
- WBX Industrial Specialties
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- WBX Consumer Discretionary
- VERU Health Care
- Exchange
- WBX Nasdaq
- VERU Nasdaq
- Market Cap
- WBX 76.3M
- VERU 85.5M
- IPO Year
- WBX N/A
- VERU 1990
- Fundamental
- Price
- WBX $3.93
- VERU $3.31
- Analyst Decision
- WBX Buy
- VERU Strong Buy
- Analyst Count
- WBX 4
- VERU 3
- Target Price
- WBX $10.50
- VERU $33.33
- AVG Volume (30 Days)
- WBX 19.9K
- VERU 216.9K
- Earning Date
- WBX 07-31-2025
- VERU 08-12-2025
- Dividend Yield
- WBX N/A
- VERU N/A
- EPS Growth
- WBX N/A
- VERU N/A
- EPS
- WBX N/A
- VERU N/A
- Revenue
- WBX $173,788,608.00
- VERU $16,886,419.00
- Revenue This Year
- WBX N/A
- VERU N/A
- Revenue Next Year
- WBX $46.25
- VERU N/A
- P/E Ratio
- WBX N/A
- VERU N/A
- Revenue Growth
- WBX N/A
- VERU 337.24
- 52 Week Low
- WBX $4.05
- VERU $2.64
- 52 Week High
- WBX $30.00
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- WBX 43.33
- VERU 33.53
- Support Level
- WBX $4.22
- VERU $3.26
- Resistance Level
- WBX $4.50
- VERU $3.53
- Average True Range (ATR)
- WBX 0.27
- VERU 0.33
- MACD
- WBX -0.08
- VERU 0.05
- Stochastic Oscillator
- WBX 4.85
- VERU 50.37
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.